Status:
ACTIVE_NOT_RECRUITING
Descriptive Study of Variations in Serum Translocation Markers of the Intestinal Microbiota in Patients With Gougerot-Sjögren Syndrome According to Disease Activity
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Sjogren's Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Gougerot-Sjögren syndrome or Sjögren syndrome is a chronic autoimmune disease belonging to connectivitis, the classic triad of symptoms being the association of a sicca syndrome (generally predominant...
Eligibility Criteria
Inclusion
- The patient must be a member or beneficiary of a health insurance plan
- Patients with primary Sjögren's syndrome according to the AECG criteria
Exclusion
- The subject is participating in a category I interventional study, or is in a period of exclusion determined by a previous study
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- Pregnant, parturient or breastfeeding patients
- Patients with secondary Sjögren's syndrome
Key Trial Info
Start Date :
November 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04462601
Start Date
November 13 2020
End Date
October 1 2028
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nimes
Nîmes, France